Rivastigmine for HIV-associated neurocognitive disorders: A randomized crossover pilot studySIMIONI, Samanta; CAVASSINI, Matthias; GIACOBINI, Ezio et al.Neurology. 2013, Vol 80, Num 6, pp 553-560, issn 0028-3878, 8 p.Article

Pharmacokinetic rationale for the rivastigmine patchCUMMINGS, Jeffrey; LEFEVRE, Gilbert; SMALL, Gary et al.Neurology. 2007, Vol 69, Num 4, issn 0028-3878, S10-S13, SUP1Conference Paper

Chemo-enzymatic synthesis of optically pure rivastigmine intermediate using alcohol dehydrogenase from baker's yeastSETHI, Madhuresh K; BHANDYA, Somashekar R; KUMAR, Anish et al.Journal of molecular catalysis. B, Enzymatic. 2013, Vol 91, pp 87-92, issn 1381-1177, 6 p.Article

Rivastigmine: an update on therapeutic efficacy in Alzheimer's disease and other conditionsGABELLI, C.Current medical research and opinion. 2003, Vol 19, Num 2, pp 69-82, issn 0300-7995, 14 p.Article

Effects of rivastigmine on cognitive function in patients with traumatic brain injurySILVER, J. M; KOUMARAS, B; GUNAY, I et al.Neurology. 2006, Vol 67, Num 5, pp 748-755, issn 0028-3878, 8 p.Article

Agrypnia with Nocturnal Confusional Behaviors in Dementia with Lewy Bodies: Immediate Efficacy of RivastigmineTERZAGHI, Michele; RUSTIONI, Valter; MANNI, Raffaele et al.Movement disorders. 2010, Vol 25, Num 5, pp 647-649, issn 0885-3185, 3 p.Article

Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer DiseaseEMRE, Murat; BERNABEI, Roberto; LEVIN, Oleg et al.CNS neuroscience & therapeutics (Print). 2010, Vol 16, Num 4, pp 246-253, issn 1755-5930, 8 p.Article

Influence of cholinesterase inhibitors, donepezil and rivastigmine on the acquisition, expression, and reinstatement of morphine-induced conditioned place preference in ratsGAWEL, Kinga; LABUZ, Krzysztof; JENDA, Malgorzata et al.Behavioural brain research. 2014, Vol 268, pp 169-176, issn 0166-4328, 8 p.Article

Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosisPORCEL, J; MONTALBAN, X.Journal of the neurological sciences. 2006, Vol 245, Num 1-2, pp 177-181, issn 0022-510X, 5 p.Conference Paper

First Case of Symmetric Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) due to Rivastigmine?ALLAIN-VEYRAC, Gwenaelle; LEBRETON, Anne; COLLONNIER, Catherine et al.American journal of clinical dermatology. 2011, Vol 12, Num 3, pp 210-213, issn 1175-0561, 4 p.Article

A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the estimation of rivastigmine in human plasmaBHATT, Jignesh; SUBBAIAH, Gunta; KAMBLI, Sandeep et al.Journal of chromatography. B. 2007, Vol 852, Num 1-2, pp 115-121, issn 1570-0232, 7 p.Article

Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's diseaseBLESA, Rafael; BULLOCK, Roger; YUNSHENG HE et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 11, pp 771-774, issn 1744-6872, 4 p.Article

Modulation of human motor cortex excitability by the cholinesterase inhibitor rivastigmineLANGGUTH, Berthold; BAUER, Elena; FEIX, Sebastian et al.Neuroscience letters. 2007, Vol 415, Num 1, pp 40-44, issn 0304-3940, 5 p.Article

Effects of Cholinesterase Inhibitors in Parkinson's Disease Dementia: A Review of Clinical DataVAN LAAR, Teus; DE DEYN, Peter Paul; AARSLAND, Dag et al.CNS neuroscience & therapeutics (Print). 2011, Vol 17, Num 5, pp 428-441, issn 1755-5930, 14 p.Article

Rivastigmine Versus Placebo in Hyperhomocysteinemic Parkinson's Disease Dementia PatientsBARONE, Paolo; BURN, David J; VAN LAAR, Teus et al.Movement disorders. 2008, Vol 23, Num 11, pp 1532-1540, issn 0885-3185, 9 p.Article

A 24-Week, Randomized, Controlled Trial of Rivastigmine Patch 13.3 mg/24 h Versus 4.6 mg/24 h in Severe Alzheimer's DementiaFARLOW, Martin R; GROSSBERG, George T; SADOWSKY, Carl H et al.CNS neuroscience & therapeutics (Print). 2013, Vol 19, Num 10, pp 745-752, issn 1755-5930, 8 p.Article

Efficacy of Rivastigmine on Executive Function in Patients with Parkinson's Disease DementiaSCHMITT, Frederick A; FARLOW, Martin R; XIANGYI MENG et al.CNS neuroscience & therapeutics (Print). 2010, Vol 16, Num 6, pp 330-336, issn 1755-5930, 7 p.Article

Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: A review based on meta-analyses by the Cochrane collaborationKURZ, A; VAN BAELEN, B.Dementia and geriatric cognitive disorders. 2004, Vol 18, Num 2, pp 217-226, issn 1420-8008, 10 p.Article

Clinical Effectiveness of Rivastigmine Monotherapy and Combination Therapy in Alzheimer's PatientsSONALI, Nirmal; TRIPATHI, Manjari; SAGAR, Rajesh et al.CNS neuroscience & therapeutics (Print). 2013, Vol 19, Num 2, pp 91-97, issn 1755-5930, 7 p.Article

LE MÉDICAMENT DU MOIS : Le patch transdermique de rivastigmine (Exelon®) = A TRANSDERMAL PATCH OF RIVASTIGMINE (EXELON®)SALMON, E.RMLG. Revue médicale de Liège. 2008, Vol 63, Num 9, pp 570-571, issn 0370-629X, 2 p.Article

Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patientsMÄURER, M; ORTLER, S; BAIER, M et al.Multiple sclerosis. 2013, Vol 19, Num 5, pp 631-638, issn 1352-4585, 8 p.Article

Effects of rivastigmine on cognitive function and quality of Life in patients with schizophreniaLENZI, Alessandro; MALTINTI, Elisabetta; POGGI, Enzo et al.Clinical neuropharmacology. 2003, Vol 26, Num 6, pp 317-321, issn 0362-5664, 5 p.Article

Prediction of treatment response to rivastigmine in Alzheimer's dementiaADLER, G; BRASSEN, S; CHWALEK, K et al.Journal of neurology, neurosurgery and psychiatry. 2004, Vol 75, Num 2, pp 292-294, issn 0022-3050, 3 p.Article

RIVASTIGMINE IN WERNICKE-KORSAKOFF'S SYNDROME: FIVE PATIENTS WITH RIVASTIGMINE SHOWED NO MORE IMPROVEMENT THAN FIVE PATIENTS WITHOUT RIVASTIGMINELUYKX, Han J; DORRESTEIJN, Lucille D. A; HAFFMANS, P. M. Judith et al.Alcohol and alcoholism (Oxford). 2008, Vol 43, Num 1, pp 70-72, issn 0735-0414, 3 p.Article

Rivastigmine, a second cholinesterase inhibitorPATTERSON, C; HOGAN, D. B.Canadian journal of neurological sciences. 2001, Vol 28, pp S122-S123, issn 0317-1671, SUP1Article